Artificial Intelligence May Allow Reduced Use of Gadolinium-based Contrast Agents
Commenting on a German study, Manisha Bahl, MD, MPH, explains how AI can be applied to breast MRI scans acquired with low doses of gadolinium-based contrast agents (GBCAs) and predict the appearance of full-dose contrast-enhanced subtraction images, a potential way to reduce the dose and therefore toxicity of GBCAs.